Phenotype-Driven In Silico Proficiency Testing Represents a Viable Approach for Undiagnosed Disorders by Exome Sequencing.

Context.--In silico mutagenesis can be performed to introduce variants into next-generation sequencing data. This method holds potential promise for proficiency testing since rare or novel variants can be modeled that are not found in available proficiency testing materials. Objective.--To determine...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Pathology & Laboratory Medicine Vol. 150; no. 6; pp. 432 - 438
Autores principales: Schmidt, Ryan J., Funke, Birgit, King, Ann, Halley, Jaimie, Hegde, Madhuri, Konnick, Eric, Lebo, Matthew, Mot, Nicole, Santani, Avni, Voelkerding, Karl, Leung, Marco L.
Formato: research tables/charts Journal Article
Publicado: College of American Pathologists Jun2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194422025&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 194422025
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00039985
        1FS
      jtl: Archives of Pathology & Laboratory Medicine
      issn: 00039985
      maglogo: N
    pubinfo:
      dt: Jun2026
      vid: 150
      iid: 6
      pid: 2550
      pub: College of American Pathologists
      place: Northfield, Illinois
    artinfo:
      ui:
        194422025
        194422025
        194422025
        10.5858/arpa.2025-0116-CP
        194422025
      ppf: 432
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Phenotype-Driven In Silico Proficiency Testing Represents a Viable Approach for Undiagnosed Disorders by Exome Sequencing.
      aug:
        au:
          Schmidt, Ryan J.
          Funke, Birgit
          King, Ann
          Halley, Jaimie
          Hegde, Madhuri
          Konnick, Eric
          Lebo, Matthew
          Mot, Nicole
          Santani, Avni
          Voelkerding, Karl
          Leung, Marco L.
        affil: Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California
      sug:
        subj:
          Computer Simulation
          Mutation
          Undiagnosed Diseases
          Sequence Analysis Methods
          Human
          Laboratories
          Bioinformatics
          Cell Line
          Phenotype
          Workflow
          Genes Evaluation
          Retrospective Design
          Record Review
          Data Analysis Software
          Nervous System Abnormalities Familial and Genetic
          Nucleotides Analysis
      ab: Context.--In silico mutagenesis can be performed to introduce variants into next-generation sequencing data. This method holds potential promise for proficiency testing since rare or novel variants can be modeled that are not found in available proficiency testing materials. Objective.--To determine whether in silico mutagenesis could be used as a viable proficiency testing methodology for undiagnosed disorders by exome sequencing. Design.--Laboratories performed exome sequencing on reference samples and uploaded raw sequence data files to the College of American Pathologists. These files were then mutagenized in silico to introduce variants, including those deemed to be causative for the clinical scenario provided. The laboratories processed the mutagenized files through their bioinformatic pipelines and performed interpretation to identify pathogenic and likely pathogenic primary and secondary findings. Responses were evaluated for concordance with intended responses. Results.--A total of 7 educational (nongraded) proficiency testing challenges were performed between 2018 and 2021. An average of 47 laboratories participated in each program, with each containing between 2 to 5 (average = 3.6) intended response variants. Intended response variant types included substitutions and small insertion/deletion variants. Participating laboratories returned 94.3% of intended response variants across all programs on average (per program range, 91.5%-97.3%). The percentage of laboratories that correctly returned all intended response variants for a program ranged from 70.0% to 96.7%. Conclusions.--In silico mutagenesis represents a suitable approach for graded intended response-based proficiency testing for exome sequencing that allows laboratories to assess both analytical and interpretative components of the test.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N